Table A4.
Survivors, Median (IQR), mg/dL | Non-Survivors, Median (IQR), mg/dL | p | Univariate Regression, OR (95%CI) | p | AUC | |
---|---|---|---|---|---|---|
n | 120 (41.4%) | 149 (51.4%) | 269 (92.8%) | 269 (92.8%) | ||
SM C16:0 | 104 (81.95, 144.50) | 110 (87, 136) | 0.56 | 1.19 (0.31, 4.63) | 0.80 | 0.52 |
SM C16:1 | 14.65 (11.35, 20) | 15.70 (11.20, 19.50) | 0.83 | 1.10 (0.28, 4.22) | 0.89 | 0.51 |
SM C18:0 | 21.65 (17.05, 31.75) | 21.70 (15.9, 29.1) | 0.54 | 0.61 (0.18, 2.07) | 0.42 | 0.52 |
SM C18:1 | 10.15 (7.465, 13.25) | 9.99 (7.01, 12.8) | 0.47 | 0.61 (0.18, 2.02) | 0.42 | 0.53 |
SM C20:2 | 0.58 (0.36, 0.89) | 0.62 (0.38, 0.87) | 0.57 | 1.25 (0.46, 3.44) | 0.66 | 0.52 |
SM C22:3 | 3.26 (2.23, 5.42) | 3.29 (2.15, 4.5) | 0.27 | 0.57 (0.23, 1.46) | 0.24 | 0.54 |
SM C24:0 | 14.50 (10.35, 19.8) | 12.80 (9.7, 16.6) | 0.06 | 0.24 (0.07, 0.86) | 0.03 | 0.57 |
SM C24:1 | 34.40 (28.6, 46.55) | 36.50 (28.9, 45.1) | 0.70 | 0.96 (0.26, 3.59) | 0.96 | 0.51 |
SM C26:0 | 0.15 (0.12, 0.22) | 0.15 (0.11, 0.23) | 0.80 | 0.68 (0.26, 1.8) | 0.44 | 0.51 |
SM C26:1 | 0.28 (0.21, 0.37) | 0.29 (0.21, 0.36) | 0.53 | 0.46 (0.14, 1.44) | 0.18 | 0.52 |
SM (OH) C14:1 | 6.48 (4.82, 8.68) | 6.88 (4.6, 9.07) | 0.95 | 0.92 (0.29, 2.93) | 0.89 | 0.50 |
SM (OH) C16:1 | 3.43 (2.66, 4.65) | 3.62 (2.33, 5.04) | 0.6 | 0.58 (0.19, 1.81) | 0.35 | 0.52 |
SM (OH) C22:1 | 9.59 (7.20, 12.9) | 8.19 (6.07, 11.3) | 0.01 | 0.18 (0.05, 0.61) | 0.01 | 0.59 |
SM (OH) C22:2 | 8.32 (6.09, 10.95) | 7.77 (5.5, 10.1) | 0.16 | 0.36 (0.1, 1.25) | 0.11 | 0.55 |
SM (OH) C24:1 | 1.07 (0.86, 1.43) | 0.97 (0.72, 1.29) | 0.02 | 0.18 (0.05, 0.69) | 0.01 | 0.58 |
Total sum of SM | 235.5 (180.9, 313.2) | 241.10 (186.80, 300.60) | 0.97 | 0.78 (0.2, 3.09) | 0.72 | 0.50 |
Data are presented as number (n) and percentage (%) or median (interquartile range) or odds ratio (OR) and 95% confidence interval (CI). SM: Sphingomyelin; AUC: Area under the curve.